FinTechFunding

Noema Pharma: Raises CHF54M in Series A Financing

  • Noema Pharma AG, a Basel, Switzerland-based clinical-stage company targeting orphan neurological disorders, raised a Series A financing round, raising CHF54m ($59m USD)
  • The round co-led by Sofinnova Partners and Polaris Partners with participation from new international investors Gilde Healthcare, Invus, and BioMed Partners
  • The company also intends to use the funds to further develop its clinical-stage pipeline
  • The product candidates will also develop in neurological indications with severe unmet need
  • Noema Pharma is a company targeting orphan neurological disorders characterized by imbalanced neuronal networks
  • The company developing four mid-clinical-stage therapeutic products in-licensed from Roche and with strong safety packages
Previous article
Bestow: Raises $70M in Series C Funding
Next article
Indico: Raises $22M in Series B Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...